John Oppenheimer

18.7k total citations · 3 hit papers
136 papers, 5.4k citations indexed

About

John Oppenheimer is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, John Oppenheimer has authored 136 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Physiology, 58 papers in Pulmonary and Respiratory Medicine and 50 papers in Immunology and Allergy. Recurrent topics in John Oppenheimer's work include Asthma and respiratory diseases (65 papers), Allergic Rhinitis and Sensitization (43 papers) and Respiratory and Cough-Related Research (38 papers). John Oppenheimer is often cited by papers focused on Asthma and respiratory diseases (65 papers), Allergic Rhinitis and Sensitization (43 papers) and Respiratory and Cough-Related Research (38 papers). John Oppenheimer collaborates with scholars based in United States, Canada and United Kingdom. John Oppenheimer's co-authors include David M. Lang, Dana Wallace, David A. Khan, Jay M. Portnoy, Richard A. Nicklas, Joann Blessing-Moore, David I. Bernstein, Linda Cox, Harold S. Nelson and Diane E. Schuller and has published in prestigious journals such as Annals of Internal Medicine, CHEST Journal and Journal of Allergy and Clinical Immunology.

In The Last Decade

John Oppenheimer

127 papers receiving 5.2k citations

Hit Papers

Allergen immunotherapy: A practice parameter third update 2008 2026 2014 2020 2010 2008 2022 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Allergen immunotherapy: A practice parameter third update
    2010 853 citations Ira Finegold, David I. Bernstein et al. Journal of Allergy and Clinical Immunology profile →
  2. The diagnosis and management of rhinitis: An updated practice parameter
    2008 764 citations David I. Bernstein, David M. Lang et al. Journal of Allergy and Clinical Immunology profile →
  3. Drug allergy: A 2022 practice parameter update
    2022 246 citations Jonathan A. Bernstein, Matthew Greenhawt et al. Journal of Allergy and Clinical Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Oppenheimer United States 35 3.3k 2.9k 1.5k 1.2k 506 136 5.4k
Joann Blessing-Moore United States 27 3.8k 1.1× 2.7k 0.9× 1.7k 1.1× 811 0.7× 402 0.8× 45 5.4k
James T. Li United States 26 2.2k 0.7× 4.0k 1.4× 761 0.5× 2.6k 2.2× 400 0.8× 66 6.0k
Richard A. Nicklas United States 31 4.4k 1.3× 3.2k 1.1× 1.9k 1.3× 1.0k 0.9× 593 1.2× 58 6.4k
Dana Wallace United States 24 3.5k 1.1× 2.2k 0.7× 1.6k 1.1× 454 0.4× 663 1.3× 53 4.8k
Gianenrico Senna Italy 40 4.2k 1.3× 2.9k 1.0× 1.6k 1.1× 1.2k 1.0× 1.2k 2.4× 279 6.8k
Anne K. Ellis Canada 36 1.9k 0.6× 1.5k 0.5× 747 0.5× 402 0.3× 497 1.0× 198 3.7k
Stephen A. Tilles United States 27 2.3k 0.7× 1.8k 0.6× 1.2k 0.8× 740 0.6× 323 0.6× 89 4.2k
Michael S. Blaiss United States 37 2.8k 0.8× 3.0k 1.0× 888 0.6× 1.2k 1.0× 97 0.2× 174 4.5k
Susanne Halken Denmark 43 6.1k 1.8× 4.1k 1.4× 2.1k 1.5× 999 0.8× 198 0.4× 128 7.7k
Phil Lieberman United States 41 3.6k 1.1× 1.7k 0.6× 1.1k 0.7× 449 0.4× 924 1.8× 201 5.4k

Countries citing papers authored by John Oppenheimer

Since Specialization
Citations

This map shows the geographic impact of John Oppenheimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Oppenheimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Oppenheimer more than expected).

Fields of papers citing papers by John Oppenheimer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Oppenheimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Oppenheimer. The network helps show where John Oppenheimer may publish in the future.

Co-authorship network of co-authors of John Oppenheimer

This figure shows the co-authorship network connecting the top 25 collaborators of John Oppenheimer. A scholar is included among the top collaborators of John Oppenheimer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Oppenheimer. John Oppenheimer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bukstein, Don A., Alan P. Baptist, Aikaterini Anagnostou, et al.. (2025). Compassionomics: Translating Evidence-Informed Patient-Centered Care to the Allergy Immunology Clinic. The Journal of Allergy and Clinical Immunology In Practice. 13(10). 2608–2618. 2 indexed citations
2.
Oppenheimer, John, et al.. (2024). Upper respiratory tract infections have minimal impact on neffy’s pharmacokinetics or pharmacodynamics. The Journal of Allergy and Clinical Immunology In Practice. 12(6). 1640–1643.e2. 9 indexed citations
3.
Busse, William W., et al.. (2024). Targeting Asthma Remission as the Next Therapeutic Step Toward Improving Disease Control. The Journal of Allergy and Clinical Immunology In Practice. 12(4). 894–903. 14 indexed citations
4.
Boulet, Louis‐Philippe, Carl Abbott, Guy Brusselle, et al.. (2024). Baseline Characteristics and ICS/LAMA/LABA Response in Asthma: Analyses From the CAPTAIN Study. The Journal of Allergy and Clinical Immunology In Practice. 12(5). 1244–1253.e8. 2 indexed citations
5.
6.
Oppenheimer, John, Huib A.M. Kerstjens, Louis‐Philippe Boulet, et al.. (2024). Characterization of Moderate and Severe Asthma Exacerbations in the CAPTAIN Study. The Journal of Allergy and Clinical Immunology In Practice. 12(9). 2372–2380.e5. 1 indexed citations
7.
Lieberman, Phil, Christopher D. Codispoti, Mahboobeh Mahdavinia, et al.. (2024). Pharmacoequity and Biologics in the Allergy Clinic: Providing the Right Care, at the Right Time, Every Time, to Everyone. The Journal of Allergy and Clinical Immunology In Practice. 12(5). 1170–1180. 12 indexed citations
8.
Golden, David M., John Oppenheimer, Carlos A. Camargo, et al.. (2023). Pharmacokinetics and pharmacodynamics of epinephrine sublingual film versus intra-muscular epinephrine. Journal of Allergy and Clinical Immunology. 151(2). AB4–AB4. 3 indexed citations
9.
10.
Meltzer, Eli O., Robert S. Zeiger, Peter V. Dicpinigaitis, et al.. (2021). Prevalence and Burden of Chronic Cough in the United States. The Journal of Allergy and Clinical Immunology In Practice. 9(11). 4037–4044.e2. 65 indexed citations
11.
12.
Greenhawt, Matthew, Marcus Shaker, Tonya Winders, et al.. (2020). Development and acceptability of a shared decision-making tool for commercial peanut allergy therapies. Annals of Allergy Asthma & Immunology. 125(1). 90–96. 43 indexed citations
13.
Abrams, Elissa M., Marcus Shaker, John Oppenheimer, et al.. (2020). The Challenges and Opportunities for Shared Decision Making Highlighted by COVID-19. The Journal of Allergy and Clinical Immunology In Practice. 8(8). 2474–2480.e1. 90 indexed citations
14.
Lee, Laurie A., Zelie Bailes, Neil Barnes, et al.. (2020). Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial. The Lancet Respiratory Medicine. 9(1). 69–84. 150 indexed citations
15.
Kuruvilla, Merin, et al.. (2020). Clinical use of biologics for asthma treatment by allergy specialists. Annals of Allergy Asthma & Immunology. 125(4). 433–439. 2 indexed citations
16.
Oppenheimer, John, et al.. (2020). The Importance of Considering Olfactory Dysfunction During the COVID-19 Pandemic and in Clinical Practice. The Journal of Allergy and Clinical Immunology In Practice. 9(1). 7–12. 21 indexed citations
17.
Shaker, Marcus, et al.. (2019). Estimation of Health and Economic Benefits of Clinic Versus Home Administration of Omalizumab and Mepolizumab. The Journal of Allergy and Clinical Immunology In Practice. 8(2). 565–572. 41 indexed citations
18.
Finegold, Ira & John Oppenheimer. (2010). Immunotherapy: the next 100 years. Annals of Allergy Asthma & Immunology. 105(5). 394–398. 2 indexed citations
19.
Youssef, Nader N., et al.. (2007). Exploring the link between eosinophilic esophagitis and esophageal foreign bodies in the pediatric population. 31(10). 81–85. 1 indexed citations
20.
Oppenheimer, John & S. Allan Bock. (1998). The ice cream parlor challenge could be a killer. Journal of Allergy and Clinical Immunology. 102(2). 325–326.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joann Blessing-Moore Breakdown of academic impact, for papers by James T. Li Breakdown of academic impact, for papers by Richard A. Nicklas Breakdown of academic impact, for papers by Dana Wallace Breakdown of academic impact, for papers by Gianenrico Senna Breakdown of academic impact, for papers by Anne K. Ellis Breakdown of academic impact, for papers by Stephen A. Tilles Breakdown of academic impact, for papers by Michael S. Blaiss Breakdown of academic impact, for papers by Susanne Halken Breakdown of academic impact, for papers by Phil Lieberman
Rankless by CCL
2026